Drug Trials Snapshot: OPDUALAG

OPDUALAG is a fixed-drug combination of nivolumab and relatlimab. OPDUALAG is used to treat adult and pediatric patients 12 years of age or older with a type of skin cancer called melanoma that cannot be removed by surgery (unresectable) or has spread to other parts of the body (metastatic).
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news